>

Imported-post

  • Cell fate signaling

    Cell fate signaling

    A newly identified protein interaction that affects cell cycle regulation may be an attractive target for cancer therapy. Read More

    December 17, 2019

  • Vanderbilt University

    Protein dynamics in the beating heart

    To study the dynamics of structural proteins in the heart, Vanderbilt investigators generated a cellular tool they expect will be useful for screening drugs that affect heart muscle contraction. Read More

    December 16, 2019

  • Vanderbilt mechanical engineers earn top materials research awards

    Vanderbilt mechanical engineers earn top materials research awards

    Vanderbilt mechanical engineers took home top awards at the Dec. 6 meeting of the Materials Research Society in Boston, Massachusetts. Mechanical engineering professor Kelsey Hatzell received the Materials Research Society Nelson “Buck” Robinson Science and Technology Award for Renewable Energy. Hatzell was selected from more than 25 candidates for her research contributions to renewable energy.... Read More

    December 13, 2019

  • Vanderbilt University

    Gore named to committee on worker health overseas

    John Gore, director of the Vanderbilt University Institute of Imaging Science, has been appointed to a National Academies of Sciences, Engineering and Medicine standing committee to advise the Department of State on unexplained health effects on U.S. government employees and their families at overseas embassies. Read More

    December 12, 2019

  • Vanderbilt University

    VUMC-led team isolates antibody that blocks bird flu

    VUMC scientists are redoubling their efforts to help people fight off bird flu. Their focus is H7N9, one of the most dangerous of the influenza viruses that have been transmitted from birds to humans. Read More

    December 12, 2019

  • Vanderbilt University

    A new anti-seizure target?

    Vanderbilt neurologists have identified a protein modification that could be targeted to reduce neuronal excitability in epilepsy. Read More

    December 12, 2019

  • Vanderbilt University

    Study examines HIV drug’s potential to treat Alzheimer’s

    A drug used to treat and prevent HIV/AIDS is showing promise as a potential therapy for Alzheimer’s disease. Read More

    December 12, 2019

  • Vanderbilt University

    New tool may speed antibody, vaccine research

    Antibody discovery and vaccine development research may be on the verge of rapidly expanding with data that previously took decades to acquire, thanks to LIBRA-seq, a new tool developed by Vanderbilt University researchers and their colleagues. Read More

    December 12, 2019

  • Vanderbilt University

    Gregor Mendel would be proud

    A computational method that uses hospital billing codes and electronic health records can identify genetic disease cases before clinical teams do. Read More

    December 12, 2019

  • Vanderbilt University

    Study reveals mysteries of critical brain receptor complex

    Poorly functioning AMPARs have been linked to a wide range of neurological and psychiatric disorders including seizures, Alzheimer’s disease, major depression and autism spectrum disorder. Understanding how AMPARs are formed and operate is essential for the rational design of pharmacological compounds that, by tuning AMPAR activity up or down, could improve treatment of these conditions. Read More

    December 5, 2019